MeSH term
Frequency | Condition_Probility | Amino Acid Substitution | 2 | 0.0 |
Child, Preschool | 5 | 0.0 |
Collagen/*genetics | 14 | 3.0 |
DNA Mutational Analysis | 3 | 0.0 |
Ehlers-Danlos Syndrome/*genetics/pathology | 5 | 83.0 |
Female | 17 | 0.0 |
Haplotypes | 3 | 0.0 |
Humans | 32 | 0.0 |
Male | 14 | 0.0 |
Microscopy, Electron | 4 | 0.0 |
Pedigree | 13 | 0.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Animals | 6 | 0.0 |
Collagen Type V/*genetics | 2 | 100.0 |
Comparative Study | 5 | 0.0 |
Exons/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Adult | 10 | 0.0 |
Alleles | 7 | 0.0 |
DNA/genetics | 2 | 0.0 |
Heterozygote | 3 | 0.0 |
Mutation | 4 | 0.0 |
Pregnancy | 2 | 0.0 |
Adolescent | 6 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Collagen/*genetics/ultrastructure | 3 | 60.0 |
Middle Aged | 4 | 0.0 |
Base Sequence | 12 | 0.0 |
Child | 6 | 0.0 |
Codon, Nonsense/genetics | 2 | 3.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Aged | 2 | 0.0 |
Ehlers-Danlos Syndrome/*genetics | 9 | 30.0 |
Gene Deletion | 2 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Collagen/chemistry/*genetics | 2 | 6.0 |
*Point Mutation | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Exons | 3 | 0.0 |
Skin/metabolism/pathology | 2 | 4.0 |
Cloning, Molecular | 3 | 0.0 |
Conserved Sequence | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Species Specificity | 2 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Genotype | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
*Mutation | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Chromosomes, Human, Pair 9 | 2 | 1.0 |
*Linkage (Genetics) | 3 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*Chromosomes, Human, Pair 9 | 6 | 2.0 |
Nail-Patella Syndrome/*genetics | 3 | 18.0 |
Telangiectasia, Hereditary Hemorrhagic/*genetics | 2 | 40.0 |
Genetic Markers | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
